ARTICLE | Clinical News
Zerviate regulatory update
March 10, 2017 8:09 PM UTC
Nicox resubmitted an NDA to FDA for Zerviate cetirizine to treat ocular itching associated with allergic conjunctivitis. Last year, FDA issued a complete response letter to Nicox for the product due ...
BCIQ Company Profiles
BCIQ Target Profiles